← Peptide library
Metabolic & weight

Tesofensine

Also known as: NS2330

An oral, non-peptide triple monoamine reuptake inhibitor commonly cited in the research literature for context on appetite and weight studies.

Tesofensine at a glance

NameTesofensine
Also known asNS2330
CategoryMetabolic & weight
TypeAmino / injectable
SequenceNon-peptide small molecule.
Typical doseCommonly cited around 0.25-0.5 mg per day in trials
FrequencyOnce daily
RouteOral
Half-lifeLong - reported on the order of several days.

Overview

Tesofensine is an investigational small-molecule compound that inhibits reuptake of noradrenaline, dopamine, and serotonin. It was originally explored for neurodegenerative conditions and later studied for effects on appetite and body weight. It is not an approved therapy in major markets.

How it’s thought to work

  • Inhibits reuptake of noradrenaline, dopamine, and serotonin.
  • Raises synaptic monoamine levels, associated with reduced appetite.
  • Central effects thought to influence energy balance and satiety.
  • Acts as an oral small molecule rather than an injectable peptide.

Researched uses

  • Weight and body-composition research
  • Appetite-regulation studies
  • Earlier neurological investigations (historical)
  • Metabolic-endpoint clinical trials

Commonly cited protocol

Typical doseCommonly cited around 0.25-0.5 mg per day in trials
FrequencyOnce daily
RouteOral
NotesTaken by mouth; no injection involved.

Reconstitution

Taken orally as a small molecule, so injection reconstitution and syringe unit math do not apply.

Cautions

  • Investigational; not FDA-approved.
  • Reported effects on heart rate, blood pressure, and mood in trials.
  • Monoamine activity carries interaction and stimulation concerns.
  • Provided for education only, not as medical advice.

Tesofensine FAQ

What is Tesofensine?

An oral, non-peptide triple monoamine reuptake inhibitor commonly cited in the research literature for context on appetite and weight studies.

How does Tesofensine work?

Inhibits reuptake of noradrenaline, dopamine, and serotonin. Raises synaptic monoamine levels, associated with reduced appetite. Central effects thought to influence energy balance and satiety. Acts as an oral small molecule rather than an injectable peptide.

What is Tesofensine used for?

Weight and body-composition research; Appetite-regulation studies; Earlier neurological investigations (historical); Metabolic-endpoint clinical trials.

What is a typical Tesofensine dose?

Commonly cited around 0.25-0.5 mg per day in trials, Once daily, Oral. This is a commonly cited figure for context only, not medical advice.

How do you reconstitute Tesofensine?

Taken orally as a small molecule, so injection reconstitution and syringe unit math do not apply.

What is the half-life of Tesofensine?

Long - reported on the order of several days.

Related metabolic & weight peptides

⚠️ Educational reference only — not medical advice. These compounds are largely research chemicals not approved for human use in most countries. Nothing here is a recommendation to obtain or administer any substance. Consult a qualified clinician.